Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host

Acute-Phase Proteins and Other Systemic Responses to Inflammation

Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734

Beyond Cholesterol

Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 4,694

Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology

Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028

C-reactive protein: a critical update

Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436

The RXR heterodimers and orphan receptors

Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,165

Identification of a nuclear receptor for bile acids

Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714

CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides

Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400

Nuclear Receptors and Lipid Physiology: Opening the X-Files

Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085

The Enzymes, Regulation, and Genetics of Bile Acid Synthesis

Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069

Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis

Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775

Cachectin and tumour necrosis factor as two sides of the same biological coin

Beutler, B., & Cerami, A. (1986) · Nature · doi:10.1038/320584a0 · Cited by 1,633

West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials

(1996) · The Lancet · doi:10.1016/s0140-6736(96)04292-4 · Cited by 1,564

Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors

Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487

Molecular physiology of reverse cholesterol transport.

Fielding, C. J., & Fielding, P. E. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39898-9 · Cited by 1,448

Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα

Peet, D. J., Turley, S. D., Ma, W., Janowski, B. A., Lobaccaro, J. A., Hammer, R. E., & Mangelsdorf, D. J. (1998) · Cell · doi:10.1016/s0092-8674(00)81432-4 · Cited by 1,428

Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus

Roman, M. J., Shanker, B., Davis, A., Lockshin, M. D., Sammaritano, L. R., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,422

Cytokine signal transduction

Kishimoto, T., Taga, T., & Akira, S. (1994) · Cell · doi:10.1016/0092-8674(94)90333-6 · Cited by 1,318

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296

Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway

Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J.-L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3137 · Cited by 1,233

Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression

Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216

Dental disease and risk of coronary heart disease and mortality.

Destefano, F. R., Anda, R. F., Kahn, H. S., Williamson, D. F., & Russell, C. M. (1993) · BMJ · doi:10.1136/bmj.306.6879.688 · Cited by 1,113

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W., Hama, S. Y., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078

Is Type II diabetes mellitus a disease of the innate immune system?

Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,042

Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα

Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005

Bile salt transporters: molecular characterization, function, and regulation

Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999

Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X Receptor

Costet, P., Luo, Y., Wang, N., & Tall, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003337200 · Cited by 981

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.

Okusawa, S., Gelfand, J. A., Ikejima, T., Connolly, R. J., & Dinarello, C. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113431 · Cited by 981

Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor

Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916

Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors

Lee, C., Olson, P., & Evans, R. M. (2003) · Endocrinology · doi:10.1210/en.2003-0288 · Cited by 891

Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus

Asanuma, Y., Oeser, A. M., Shintani, A., Turner, E. L., Olsen, N. J., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 889

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

Kugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R., & Henry, P. D. (1990) · Nature · doi:10.1038/344160a0 · Cited by 858

Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors α and β

Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H. H., & Mangelsdorf, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109927200 · Cited by 852

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

Grünfeld, C., Pang, M., Doerrler, W. T., Shigenaga, J. K., Jensen, P., & Feingold, K. R. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1373735 · Cited by 845

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

Lenten, B. J. V., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., Du, B. N. L., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 839

Lipoprotein-Associated Phospholipase A 2 as an Independent Predictor of Coronary Heart Disease

Packard, C. J., O’Reilly, D. S. J., CASLAKE, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 822

Human Bile Salt Export Pump Promoter Is Transactivated by the Farnesoid X Receptor/Bile Acid Receptor

Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 804

Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

Saikku, P., Leinonen, M., Tenkanen, L., Linnanmäki, E., Ekman, M.-R., Manninen, V., Mänttäri, M., Frick, M. H., & Huttunen, J. K. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-273 · Cited by 785

Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol

Yu, L., Li-Hawkins, J., Hammer, R. E., Berge, K. E., Horton, J. D., Cohen, J. C., & Hobbs, H. H. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16001 · Cited by 727

Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion

Yu, L., Hammer, R. E., Li-Hawkins, J., von Bergmann, K., Lütjohann, D., Cohen, J. C., & Hobbs, H. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252582399 · Cited by 722

High Density Lipoproteins and Arteriosclerosis

von Eckardstein, A., Nofer, J., & Assmann, G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.13 · Cited by 696

ANIMAL GLYCOSPHINGOLIPIDS AS MEMBRANE ATTACHMENT SITES FOR BACTERIA

Karlsson, K. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.001521 · Cited by 682

Relation of Helicobacter pylori infection and coronary heart disease.

Mendall, M. A., Goggin, P. M., Molineaux, N., Levy, J., Toosy, T., Strachan, D. P., Camm, A. J., & Northfield, T. C. (1994) · Heart · doi:10.1136/hrt.71.5.437 · Cited by 657

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

Quinn, M. T., Parthasarathy, S., & Steinberg, D. H. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2805 · Cited by 650

Nuclear Receptors and the Control of Metabolism

Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. H. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 647

Peroxisome Proliferator–Activated Receptor γ and Metabolic Disease

Willson, T. M., Lambert, M. H., & Kliewer, S. A. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.341 · Cited by 590

Roles of Infectious Agents in Atherosclerosis and Restenosis

Libby, P., Egan, D., & Skarlatos, S. I. (1997) · Circulation · doi:10.1161/01.cir.96.11.4095 · Cited by 559

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

Chait, A., Brazg, R., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

Chang, M.-K., Binder, C. J., Torzewski, M., & Witztum, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192399699 · Cited by 521

Infection and Atherosclerosis

Epstein, S. E., Zhou, Y., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 512

Apolipoprotein L-I is the trypanosome lytic factor of human serum

Vanhamme, L., Paturiaux-Hanocq, F., Poelvoorde, P., Nolan, D. P., Lins, L., Abbeele, J. V. D., Pays, A., Tebabi, P., Xong, H. V., Jacquet, A., et al. (2003) · Nature · doi:10.1038/nature01461 · Cited by 511

Chronic Infections and the Risk of Carotid Atherosclerosis

Kiechl, S. J., Egger, G., Mayr, M., Wiedermann, C. J., Bonora, E., Oberhollenzer, F., Muggeo, M., Xu, Q., Wick, G., Poewe, W. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.8.1064 · Cited by 508

Orphan Nuclear Receptors: Shifting Endocrinology into Reverse

Kliewer, S. A., Lehmann, J. M., & Willson, T. M. (1999) · Science · doi:10.1126/science.284.5415.757 · Cited by 499

Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism

Castrillo, A., Joseph, S. B., Vaidya, S. A., Haberland, M. E., Fogelman, A. M., Cheng, G., & Tontonoz, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00384-8 · Cited by 498

Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors

Chiang, J. Y. L. (2002) · Endocrine Reviews · doi:10.1210/er.2000-0035 · Cited by 487

In vivo protection against endotoxin by plasma high density lipoprotein.

Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485

ABCA1: the gatekeeper for eliminating excess tissue cholesterol

Oram, J. F., & Lawn, R. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31566-2 · Cited by 481

Members of the low density lipoprotein receptor familymediate cell entry of a minor-group common cold virus.

Hofer, F., Gruenberger, M., Kowalski, H., Machat, H., Huettinger, M., Kuechler, E., & Blass, D. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1839 · Cited by 468

Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.

Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442

Tumor Necrosis Factor-α Stimulates Lipolysis in Differentiated Human Adipocytes Through Activation of Extracellular Signal-Related Kinase and Elevation of Intracellular cAMP

Zhang, H., Halbleib, M., Ahmad, F., Manganiello, V. C., & Greenberg, A. S. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2929 · Cited by 436

A novel endothelial-derived lipase that modulates HDL metabolism

Jaye, M., Lynch, K. J., Krawiec, J., Marchadier, D., Maugeais, C., Doan, K., South, V., Amin, D., Perrone, M., & Rader, D. J. (1999) · Nature Genetics · doi:10.1038/7766 · Cited by 427

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

Pajkrt, D., Doran, J., Koster, F., Lerch, P., Arnet, B., van der Poll, T., ten Cate, J. W., & van Deventer, S. V. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.184.5.1601 · Cited by 427

Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition.

Coetzee, G. A., Strachan, A. F., van der Westhuyzen, D. R., Hoppe, H., Jeenah, M. S., & de Beer, F. C. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67562-3 · Cited by 426

Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

Fruchart, J.-C., Duriez, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00007 · Cited by 425

Inflammatory status and insulin resistance

Grimble, R. F. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200209000-00015 · Cited by 411

Tumor necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway

Xia, P., Gamble, J. R., Rye, K., Wang, L., Hii, C. S. T., Cockerill, P. N., Khew‐Goodall, Y., Bert, A. G., Barter, P. J., & Vadas, M. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14196 · Cited by 408

Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.

Feingold, K. R., & Grünfeld, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113046 · Cited by 403

Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins

Khovidhunkit, W., Memon, R. A., Feingold, K. R., & Grünfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403

Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems

Krieger, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14011 · Cited by 402

The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis

Lambert, G. C., Amar, M. J., Guo, G. L., Brewer, H. B., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209525200 · Cited by 401

Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.

Stafforini, D. M., McIntyre, T. M., Carter, M. E., & Prescott, S. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61335-3 · Cited by 398

The LXRs: a new class of oxysterol receptors.

Peet, D. J., Janowski, B. A., & Mangelsdorf, D. (1998) · Current Opinion in Genetics and Development · doi:10.1016/s0959-437x(98)80013-0 · Cited by 393

BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis

Edwards, P. A., Kast-Woelbern, H. R., & Anisfeld, A. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30180-2 · Cited by 387

Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease

Jiang, X.-C., Paultre, F., Pearson, T. A., Reed, R. G., Francis, C. K., Lin, M., Berglund, L., & Tall, A. R. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2614 · Cited by 387

Novel Inflammatory Markers of Coronary Risk

Libby, P., & Ridker, P. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1148 · Cited by 375

Serum Lipids in Infection

Gallin, J. I., Kaye, D., & O’Leary, W. M. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911132812001 · Cited by 375

Protective role of phospholipid oxidation products in endotoxin-induced tissue damage

Bochkov, V. N., Kadl, A., Huber, J., Грубер, Ф., Binder, B. R., & Leitinger, N. (2002) · Nature · doi:10.1038/nature01023 · Cited by 367

Transient changes of serum lipoprotein(a) as an acute phase protein

Maeda, S., Abe, A., Seishima, M., Makino, K., Noma, A., & KAWADE, M. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90218-9 · Cited by 366

The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes

Kuivenhoven, J. A., Pritchard, H., Hill, J. S., Frohlich, J., Assmann, G., & Kastelein, J. J. P. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37433-2 · Cited by 364

Stimulation of Lipolysis and Hormone-sensitive Lipase via the Extracellular Signal-regulated Kinase Pathway

Greenberg, A. S., Shen, W., Muliro, K. V., Patel, S., Souza, S. C., Roth, R. A., & Kraemer, F. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104436200 · Cited by 363

Up–Regulation of the Multidrug Resistance Genes, Mrp1 And Mdr1b , and Down–Regulation of the Organic Anion Transporter, Mrp2, and the Bile Salt Transporter, Spgp, in Endotoxemic Rat Liver

Vos, T. A., Hooiveld, G. J. E. J., Koning, H., Childs, S. J., Meijer, D. K. F., Moshage, H. J., Jansen, P. L. M., & Müller, M. M. (1998) · Hepatology · doi:10.1002/hep.510280625 · Cited by 362

Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element

Luo, Y., & Tall, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8573 · Cited by 357

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

Monazahian, M., B�hme, I., Bonk, S., Koch, A., Scholz, C., Grethe, S., & THOMSSEN, R. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199903)57:3 · Cited by 357

Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: a Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids

Kast-Woelbern, H. R., Nguyen, C., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 354

Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients

Drobnik, W., Liebisch, G., Audebert, F., Fröhlich, D., Glück, T., Vogel, P. M., Rothe, G., & Schmitz, G. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200401-jlr200 · Cited by 350

Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.

Feingold, K., Staprãns, I., Memon, R., Moser, A. H., Shigenaga, J. K., Doerrler, W. T., Dinarello, C. A., & Grünfeld, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41334-3 · Cited by 346

Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection

Jack, R. S., Fan, X., Bernheiden, M., Rune, G. M., Ehlers, M., Weber, A., Kirsch, G., Mentel, R., Fürll, B., Freudenberg, M. A., et al. (1997) · Nature · doi:10.1038/39622 · Cited by 345

LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.

Lamping, N., Dettmer, R., Schröder, N. W. J., Pfeil, D., Hallatschek, W., Burger, R., & Schumann, R. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2338 · Cited by 345

Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.

Schissel, S. L., Tweedie-Hardman, J., Rapp, J. H., Graham, G., Williams, K. J., & Tabas, I. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118934 · Cited by 342

Therapeutic effects of lysophosphatidylcholine in experimental sepsis

Yan, J.-J., JUNG, J., Lee, J.-E., Lee, J.-H., Huh, S., Kim, H., Jung, K. C., Cho, J., Nam, J., Suh, H., et al. (2004) · Nature Medicine · doi:10.1038/nm989 · Cited by 328

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha

Zhang, B., Berger, J., Hu, E., Szalkowski, D., White-Carrington, S., Spiegelman, B. M., & Moller, D. E. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.11.8923470 · Cited by 328

Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor.

Nigon, F., Lesnik, P., Rouis, M., & Chapman, M. J. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41629-3 · Cited by 325

High-Density Lipoprotein Loses Its Anti-Inflammatory Properties During Acute Influenza A Infection

Lenten, B. J. V., Wagner, A. C., Nayak, D. P., Hama, S. Y., Navab, M., & Fogelman, A. M. (2001) · Circulation · doi:10.1161/01.cir.103.18.2283 · Cited by 323

Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice.

Harris, H. W., Grünfeld, C., Kr, F., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 321

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

Spriggs, D. R., Sherman, M. L., MICHIE, H. R., Arthur, K. A., Imamura, K., Wilmore, D. W., Frei, E., & Kufe, D. W. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.13.1039 · Cited by 309

Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents

Rm, G., Beier, D. R., & Gollan, J. L. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8698199 · Cited by 309

Interleukin-10

Malefyt, R. D. W., Yssel, H., Roncarolo, M., Spits, H., & de Vries, J. E. (1992) · Current Opinion in Immunology · doi:10.1016/0952-7915(92)90082-p · Cited by 308

Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins.

Cabana, V. G., Siegel, J. N., & Sabesin, S. M. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38390-5 · Cited by 307

Endothelial lipase is a major determinant of HDL level

Ishida, T., Choi, S. Y., Kundu, R. K., Hirata, K., Rubin, E. M., Cooper, A. D., & Quertermous, T. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16306 · Cited by 306

Interleukin-6 stimulates hepatic triglyceride secretion in rats

Nonogaki, K., Fuller, G. M., Fuentes, N. L., Moser, A. H., Staprãns, I., Grünfeld, C., & Feingold, K. R. (1995) · Endocrinology · doi:10.1210/endo.136.5.7720663 · Cited by 305

Orphan nuclear receptors—new ligands and new possibilities: Figure 1.Preprint

Blumberg, B., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3149 · Cited by 304

New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides.

Ulevitch, R. J., Johnston, A. R., & Weinstein, D. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109610 · Cited by 298

Tumor necrosis factor and the acute metabolic response to tissue injury in man.

Starnes, H. F., Warren, R. S., Jeevanandam, M., Gabrilove, J. L., Larchian, W. A., Oettgen, H. F., & Brennan, M. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113733 · Cited by 298

Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells.

Patton, J. S., Shepard, H. M., Wilking, H., Lewis, G., Aggarwal, B. B., Eessalu, T. E., Gavin, L. A., & Grünfeld, C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8313 · Cited by 277

Changes in serum lipoprotein pattern induced by acute infections

Sammalkorpi, K., Valtonen, V., Kerttula, Y., Nikkilä, E. A., & Taskinen, M. (1988) · Metabolism · doi:10.1016/0026-0495(88)90120-5 · Cited by 275

Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors.

Trauner, M. A., Arrese, M. A., Lee, H., Boyer, J. L., & Karpen, S. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1680 · Cited by 265

Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

Ehrenwald, E., Chisolm, G. M., & Fox, P. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117127 · Cited by 262

Effects of tumour necrosis factor alpha (TNFα) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture

Hauner, H., Petruschke, T., Russ, M., Röhrig, K., & Eckel, J. (1995) · Diabetologia · doi:10.1007/s001250050350 · Cited by 261

New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism

Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255

Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages

Artl, A., Marsche, G., Lestavel, S., Sattler, W., & Malle, E. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.763 · Cited by 254

Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response

Feingold, K. R., Memon, R. A., Moser, A. H., & Grünfeld, C. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00084-7 · Cited by 248

Evidence for infectious agents in cardiovascular disease and atherosclerosis

Leinonen, M., & Saikku, P. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00168-2 · Cited by 248

Cytokines in the Pathogenesis of Atherosclerosis

Young, J. B., Libby, P., & Schönbeck, U. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613256 · Cited by 247

Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1)

Zhang, M., & Chiang, J. Y. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105117200 · Cited by 244

Role of Group II Secretory Phospholipase A2in Atherosclerosis

Ivandic, B., Castellani, L. W., Wang, X.-P., Qiao, J.-H., Mehrabian, M., Navab, M., Fogelman, A. M., Grass, D., Swanson, M. E., de Beer, M. C., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1284 · Cited by 244

Symptoms of chronic bronchitis and the risk of coronary disease

Jousilahti, P., Vartiainen, E. A., Tuomilehto, J. O., & Puska, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02374-4 · Cited by 244

Stimulation of Hepatic Acute Phase Response by Cytokines and Glucocorticoidsa

BAUMANN, H., Prowse, K. R., MARINKOVIĆ, S., Won, K. A., & Jahreis, G. P. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24021.x · Cited by 240

The Farnesoid X-activated Receptor Mediates Bile Acid Activation of Phospholipid Transfer Protein Gene Expression

Urizar, N. L., Dowhan, D. H., & Moore, D. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007998200 · Cited by 238

Distribution and Kinetics of Lipoprotein-Bound Endotoxin

Levels, J. H. M., Abraham, P. R., van den Ende, A., & van Deventer, S. J. H. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.2821-2828.2001 · Cited by 234

Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis

Fajas, L., Debril, M.-B., & Auwerx, J. H. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0270001 · Cited by 232

Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men

Lamarche, B., Uffelman, K. D., Carpentier, A. C., Cohn, J. S., Steiner, G., Barrett, P. H. R., & Lewis, G. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5286 · Cited by 230

The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver

Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000953200 · Cited by 223

Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo

Jin, W., Millar, J. S., Broedl, U. C., Glick, J. M., & Rader, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16146 · Cited by 217

Human Plasma Platelet-Activating Factor Acetyl hydrolase

Stafforini, D. M., & Tjoelker, L. W. (2003) · Humana Press eBooks · doi:10.1385/1-59259-581-2:49 · Cited by 216

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism.

Sherman, M. L., Spriggs, D. R., Arthur, K. A., Imamura, K., Frei, E., & Kufe, D. W. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.344 · Cited by 215

Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.

Steinbrecher, U. P., & Pritchard, P. H. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38359-0 · Cited by 215

Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.

Harris, H. W., Grünfeld, C., Feingold, K. R., Read, T. E., Kane, J. P., Jones, A. L., Eichbaum, E. B., Bland, G. F., & Rapp, J. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116259 · Cited by 214

Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function.

Kisilevsky, R., & Subrahmanyan, L. (1992) · PubMed · Cited by 213

Do atherosclerosis and type 2 diabetes share a common inflammatory basis?

Pradhan, A. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3052 · Cited by 212

Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood

Parker, T. S., Levine, D. M., Chang, J. C., Laxer, J., Coffin, C. C., & Rubin, A. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.253-258.1995 · Cited by 211

Multiple Cytokines Stimulate Hepatic Lipid Synthesisin Vivo*

FEINGOLD, K. R., Soued, M., Serio, M., MOSER, A. H., Dinarello, C. A., & Grünfeld, C. (1989) · Endocrinology · doi:10.1210/endo-125-1-267 · Cited by 210

Role for circulating lipoproteins in protection from endotoxin toxicity

Feingold, K. R., Funk, J. L., Moser, A. H., Shigenaga, J. K., Rapp, J. H., & Grünfeld, C. (1995) · Infection and Immunity · doi:10.1128/iai.63.5.2041-2046.1995 · Cited by 210

Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in Endotoxemia

Hartmann, G., Cheung, A. K. Y., & Piquette‐Miller, M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039404 · Cited by 210

Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection

de Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., & Stalenhoef, A. F. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32147-7 · Cited by 210

Infection and Inflammation Induce LDL Oxidation In Vivo

Memon, R. A., Staprãns, I., Noor, M. A., Holleran, W. M., Uchida, Y., Moser, A. H., Feingold, K. R., & Grünfeld, C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1536 · Cited by 207

Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe gram-negative infections.

Netea, M. G., Demacker, P. N. M., Kullberg, B. J., Boerman, O. C., Verschueren, I., Stalenhoef, A. F. H., & van der Meer, J. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118556 · Cited by 207

Lipopolysaccharide (LPS)-Binding Protein Mediates LPS Detoxification by Chylomicrons

Vreugdenhil, A. C. E., Rousseau, C. H., Härtung, T., Greve, J. W. M., Veer, C. V. ′., & Buurman, W. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1399 · Cited by 206

Psoriasis and occlusive vascular disease

McDonald, C. J., & Calabresi, P. (1978) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1978.tb02012.x · Cited by 205

Mortality among arthritics

Monson, R. R., & Hall, A. P. (1976) · Journal of Chronic Diseases · doi:10.1016/0021-9681(76)90086-2 · Cited by 202

Molecular Biology of Interleukin 4 and Interleukin 5 Genes and Biology of their Products that Stimulate B Cells, T Cells and Hemopoietic Cells

Yokota, T., Arai, N., de Vries, J. E., Spits, H., Banchereau, J., Zlotnik, A., Rennick, D. M., Howard, M., Takebe, Y., Miyatake, S., et al. (1988) · Immunological Reviews · doi:10.1111/j.1600-065x.1988.tb00744.x · Cited by 201

Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells.

Ettinger, W. H., Varma, V. K., Sorci‐Thomas, M. G., Parks, J. S., Sigmon, R. C., Smith, T. K., & Verdery, R. B. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.8 · Cited by 196

Tumor necrosis factor mediates the effects of endotoxin on cholesterol and triglyceride metabolism in mice

Memon, R. A., Grünfeld, C., Moser, A. H., & Kr, F. (1993) · Endocrinology · doi:10.1210/endo.132.5.8477669 · Cited by 193

Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response

Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00196-1 · Cited by 192

Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions.

Hoffman, J. S., & Benditt, E. P. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34047-x · Cited by 190

Overexpression of Secretory Phospholipase A2 Causes Rapid Catabolism and Altered Tissue Uptake of High Density Lipoprotein Cholesteryl Ester and Apolipoprotein A-I*

Tietge, U., Maugeais, C., Cain, W. J., Grass, D., Glick, J., de Beer, F. D., & Rader, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10077 · Cited by 190

Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism

Ma, K., Cilingiroglu, M., Otvos, J. D., Ballantyne, C. M., Marian, A. J., & Chan, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438039100 · Cited by 189

TNF -Mediated Inhibition and Reversal of Adipocyte Differentiation Is Accompanied by Suppressed Expression of PPAR without Effects on Pref-1 Expression

Xing, H. Y., Northrop, J. P., Grove, J. R., Kilpatrick, K. E., Su, J., & RINGOLD, G. M. (1997) · Endocrinology · doi:10.1210/endo.138.7.5242 · Cited by 189

A Chlamydia pneumoniae Component That Induces Macrophage Foam Cell Formation Is Chlamydial Lipopolysaccharide

Kalayoglu, M. V., & Byrne, G. I. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5067-5072.1998 · Cited by 189

Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide

Cavaillon, J., Fitting, C., Haeffner‐Cavaillon, N., Kirsch, S. J., & Warren, H. S. (1990) · Infection and Immunity · doi:10.1128/iai.58.7.2375-2382.1990 · Cited by 186

Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality

Van Oosten, M., Rensen, P. C. N., Van Amersfoort, E. S., Van Eck, M., Van Dam, A.-M., Brevé, J. J. P., Vogel, T., Panet, A., Van Berkel, T. J. C., & Kuiper, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009915200 · Cited by 186

The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide.

Lenten, B. J. V., Fogelman, A. M., Haberland, M. E., & Edwards, P. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2704 · Cited by 185

Cytomegalovirus and atherosclerosis.

Melnick, J. L., Adam, E., & DeBakey, M. E. (1993) · PubMed · Cited by 183

Specific Phospholipid Oxidation Products Inhibit Ligand Activation of Toll-Like Receptors 4 and 2

Walton, K. A., Cole, A. L., Yeh, M. W., Subbanagounder, G., Krutzik, S. R., Modlin, R. L., Lucas, R. M., Nakai, J., Smart, E. J., Vora, D. K., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000079340.80744.b8 · Cited by 183

Tumor Necrosis Factor Stimulates Hepatic Lipid Synthesis and Secretion*

FEINGOLD, K. R., Serio, M., Adi, S., MOSER, A. H., & Grünfeld, C. (1989) · Endocrinology · doi:10.1210/endo-124-5-2336 · Cited by 183

Human Recombinant TNF Suppresses Lipoprotein Lipase Activity and Stimulates Lipolysis in 3T3-L1 Cells1

KAWAKAMI, M., MURASE, T., OGAMA, H., ISHIBASHI, S., MORI, N., TAKAKU, F., & SHIBATA, S. (1987) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a121917 · Cited by 183

The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B.

Kr, F., Krauss, R. M., Pang, M., Doerrler, W. T., Jensen, P. B., & Grünfeld, C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501146 · Cited by 182

Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein.

de Beer, F. C., Soutar, A. K., Baltz, M. L., Trayner, I., Feinstein, A., & Pepys, M. B. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.156.1.230 · Cited by 182

Neutralization and Transfer of Lipopolysaccharide by Phospholipid Transfer Protein

Hailman, E., Albers, J. J., Wolfbauer, G., Tu, A. Y., & Wright, S. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.21.12172 · Cited by 181

Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.

Feingold, K. R., Harðardóttir, I., Memon, R. A., Krul, E. J. T., Moser, A. H., Taylor, J. M., & Grünfeld, C. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35355-4 · Cited by 181

Periodontitis decreases the antiatherogenic potency of high density lipoprotein

Pussinen, P. J., Jauhiainen, M., Vilkuna-Rautiainen, T., Sundvall, J., Vesanen, M., Mattila, K. J., Palosuo, T., Alfthan, G., & Asikainen, S. E. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300250-jlr200 · Cited by 173

Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation

Funk, J. L., Feingold, K. R., Moser, A. H., & Grünfeld, C. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90224-i · Cited by 172

Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase

Green, A., Dobias, S. B., Walters, D. J., & Brasier, A. R. (1994) · Endocrinology · doi:10.1210/endo.134.6.8194485 · Cited by 171

Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.

Li, M., Zhou, J., Sasano, H., Suzuki, T., Zeitoun, K. M., & Bulun, S. E. (2001) · PubMed · Cited by 169

Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I

Flegel, W. A., Baumstark, M. W., Weinstock, C., Berg, A., & Northoff, H. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5140-5146.1993 · Cited by 169

Gene Regulatory Mechanisms Governing Energy Metabolism during Cardiac Hypertrophic Growth

Lehman, J. J., & Kelly, D. P. (2002) · Heart Failure Reviews · doi:10.1023/a:1015332726303 · Cited by 166

LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction

Vreugdenhil, A. C. E., Snoek, A. M. P., Veer, C. V. ′., Greve, J.-W. M., & Buurman, W. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10832 · Cited by 166

Lipopolysaccharide Binding Protein and Serum Amyloid A Secretion by Human Intestinal Epithelial Cells During the Acute Phase Response

Vreugdenhil, A. C. E., Dentener, M. A., Snoek, A. M. P., Greve, J.-W. M., & Buurman, W. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2792 · Cited by 166

Endotoxin and Cytokines Increase Hepatic Sphingolipid Biosynthesis and Produce Lipoproteins Enriched in Ceramides and Sphingomyelin

Memon, R. A., Holleran, W. M., Moser, A. H., Seki, T., Uchida, Y., Fuller, J., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.8.1257 · Cited by 165

Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages.

Hurt‐Camejo, E., Camejo, G., Rosengren, B. E., Lopez, F., Wiklund, O., & Bondjers, G. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42610-0 · Cited by 162

Sphingomyelinase enhances low density lipoprotein uptake and ability to induce cholesteryl ester accumulation in macrophages.

Xu, X. X., & Tabas, I. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54306-4 · Cited by 161

Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice

Kok, T., Bloks, V. W., Wolters, H., Havinga, R., Jansen, P. L. M., Staels, B., & Kuipers, F. (2003) · Biochemical Journal · doi:10.1042/bj20020981 · Cited by 161

Characterization of a Novel Trypanosome Lytic Factor from Human Serum

Raper, J., Fung, R., Ghiso, J. A., Nussenzweig, V., & Tomlinson, S. (1999) · Infection and Immunity · doi:10.1128/.67.4.1910-1916.1999 · Cited by 158

Production of the Acute-Phase Protein Lipopolysaccharide-Binding Protein by Respiratory Type II Epithelial Cells: Implications for Local Defense to Bacterial Endotoxins

Dentener, M. A., Vreugdenhil, A. C. E., Hoet, P., Vernooy, J. H. J., Nieman, F. H. M., Heumann, D., Janssen-Heininger, Y. M. W., Buurman, W. A., & Wouters, E. F. �. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.23.2.3855 · Cited by 158

Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo : A possible link between inflammatory cytokines and atherogenesis

Wong, M., Xie, B., Beatini, N., Phu, P., Marathe, S. V., Johns, A., Gold, P. W., Hirsch, E., Williams, K. J., Licinio, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150098097 · Cited by 157

Repression of Farnesoid X Receptor during the Acute Phase Response

Kim, M. S., Shigenaga, J. K., Moser, A., Feingold, K. R., & Grünfeld, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212633200 · Cited by 157

Effect of endotoxin on bile acid transport in rat liver: a potential model for sepsis-associated cholestasis

Moseley, R. H., Wang, W., Takeda, H., Lown, K., Shick, L., Ananthanarayanan, M., & Suchy, F. J. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.1.g137 · Cited by 157

In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins

Emancipator, K., Csákó, G., & Elin, R. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.2.596-601.1992 · Cited by 154

Bimodal Regulation of Ceramidase by Interleukin-1β

Nikolova‐Karakashian, M., Morgan, E. T., Alexander, C. W., Liotta, D. C., & Merrill, A. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18718 · Cited by 153

Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins

Flegel, W. A., Wolpl, A., Männel, D. N., & Northoff, H. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2237-2245.1989 · Cited by 148

Interferon-γ-induced Regulation of Peroxisome Proliferator-activated Receptor γ and STATs in Adipocytes

Waite, K. J., Floyd, Z. E., Arbour-Reily, P., & Stephens, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007894200 · Cited by 145

Lipoproteins inhibit macrophage activation by lipoteichoic acid

Grünfeld, C., Marshall, M. K., Shigenaga, J. K., Moser, A. H., Tobias, P. S., & Feingold, K. R. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33363-0 · Cited by 143

Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW Cells

Baranova, I. N., Vishnyakova, T. G., Bocharov, A. V., Chen, Z., Remaley, A. T., Stonik, J. A., Eggerman, T. L., & Patterson, A. P. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.2995-3003.2002 · Cited by 142

Altered expression of nuclear hormone receptors and coactivators in mouse heart during the acute-phase response

Feingold, K. R., Kim, M. S., Shigenaga, J. K., Moser, A., & Grünfeld, C. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2003 · Cited by 142

Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages

Khovidhunkit, W., Moser, A. H., Shigenaga, J. K., Grünfeld, C., & Feingold, K. R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300100-jlr200 · Cited by 142

A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers

Hudgins, L. C., Parker, T. S., Levine, D. M., Gordon, B. R., Saal, S. D., Jiang, X., Seidman, C. E., Tremaroli, J. D., Lai, J., & Rubin, A. L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200440-jlr200 · Cited by 141

A risk factor for atherosclerosis: triglyceride-rich lipoproteins.

Mj, M., & Jp, K. (2001) · PubMed · Cited by 141

Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms

Doerrler, W. T., Feingold, K. R., & Grünfeld, C. (1994) · Cytokine · doi:10.1016/1043-4666(94)90074-4 · Cited by 137

Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.

Kunitake, S. T., Jarvis, M. R., Hamilton, R. L., & Kane, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6993 · Cited by 137

Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines

Memon, R. A., Feingold, K. R., Moser, A. H., Fuller, J., & Grünfeld, C. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.274.2.e210 · Cited by 137

LXRα is the dominant regulator of CYP7A1 transcription

Gupta, S., Pandak, W. M., & Hylemon, P. B. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00229-2 · Cited by 135

Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.

Jeong, T., Schissel, S. L., Tabas, I. A., Pownall, H. J., Tall, A. R., & Jiang, X. (1998) · Journal of Clinical Investigation · doi:10.1172/jci870 · Cited by 133

α1-Fetoprotein Transcription Factor Is Required for the Expression of Sterol 12α-Hydroxylase, the Specific Enzyme for Cholic Acid Synthesis

del Castillo‐Olivares, A., & Gil, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000996200 · Cited by 133

Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.

Feingold, K. R., Soued, M., Staprãns, I., Gavin, L. A., Donahue, M. E., Huang, B. J., Moser, A. H., Gulli, R., & Grünfeld, C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113991 · Cited by 132

1999 George Lyman Duff Memorial Lecture

Tall, A. R., Jiang, X., Luo, Y., & Silver, D. L. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1185 · Cited by 130

Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors

Mak, P. A., Kast-Woelbern, H. R., Anisfeld, A. M., & Edwards, P. A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.c200014-jlr200 · Cited by 130

Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction.

Clifton, P. M., Mackinnon, A. M., & Barter, P. J. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34244-9 · Cited by 130

HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease

Cabana, V. G., Lukens, J. R., Rice, K. S., Hawkins, T., & Getz, G. S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37469-1 · Cited by 129

Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins

Pruzanski, W., Stefanski, E., de Beer, F. C., de Beer, M. C., Ravandi, A., & Kuksis, A. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32007-1 · Cited by 128

Human Secretory Phospholipase A2Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice

Tietge, U. J. F., Maugeais, C., Lund‐Katz, S., Grass, D., deBeer, F. C., & Rader, D. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000023228.90866.29 · Cited by 126

Inflammation, stress, and diabetes

Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143

The immunology of atherosclerosis

Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

Kontush, A., & Chapman, M. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.1 · Cited by 647

Increased Infiltration of Macrophages in Omental Adipose Tissue Is Associated With Marked Hepatic Lesions in Morbid Human Obesity

Cancello, R., Tordjman, J., Poitou, C., Guilhem, G., Bouillot, J. L., Hugol, D., Coussieu, C., Basdevant, A., Hen, A. B., Bedossa, P., et al. (2006) · Diabetes · doi:10.2337/db06-0133 · Cited by 607

Large-Scale Multi-omic Analysis of COVID-19 Severity

Overmyer, K. A., Shishkova, E., Miller, I. J., Balnis, J., Bernstein, M. N., Peters-Clarke, T. M., Meyer, J. G., Quan, Q., Muehlbauer, L. K., Trujillo, E. A., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.10.003 · Cited by 607

Infection and Inflammation‐Induced Proatherogenic Changes of Lipoproteins

Khovidhunkit, W., Memon, R. A., Feingold, K. R., & Grünfeld, C. (2000) · The Journal of Infectious Diseases · doi:10.1086/315611 · Cited by 403

Infection and In¯ammation-Induced Proatherogenic Changes of Lipoproteins

Khovidhunkit, W., Memon, R. A., Feingold, K. R., & Grünfeld, C. (2016)

The Effect of Inflammation and Infection on Lipids and Lipoproteins

Feingold, K. R., & Grünfeld, C. (2015) · Europe PMC (PubMed Central) · Cited by 126

Infection and Inflammation Induce LDL Oxidation In Vivo

Memon, R. A., Staprãns, I., Noor, M. A., Holleran, W. M., Uchida, Y., Moser, A. H., Feingold, K. R., & Grünfeld, C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1536 · Cited by 207

The acute phase response inhibits reverse cholesterol transport

Feingold, K. R., & Grünfeld, C. (2010) · Journal of Lipid Research · doi:10.1194/jlr.e005454 · Cited by 102